000			03539nam a22003257a 4500
003			OSt
005			20240305192450.0
008			220608b |||||||| |||| 00| 0 eng d
020			_a1849963843
020			_a9781849963848
040			_cdlc
082			_a616.724
100			_aRuediger Mueller _938670
245			_aClinical Trials in Rheumatology
250			_a illustrated
260			_aDivision of Rheumatology and Rehabilitation Department of Internal Medicine Kantonsspital St. Gallen Switzerland _bSpringer Science & Business Media _c2010
300			_a747 pages
505			_aContents: Rheumatoid Arthritis Ankylosing Spondylitis Psoriatic Arthritis Systemic Lupus Erythematosus Antiphospholipid Syndrome Progressive Systemic Sclerosis Raynauds Phenomenon DermatoPolymyositis Takayasu Arteritis Giant Cell Arteritis Polymyalgia Rheumatica ANCAAssociated Vasculitis Churg Strauss syndrome Polyarteritis Nodosa and other vasculitic entities Purpura Schoenlein Henoch Morbus Behçet Abbreviations Index Sjögrens Syndrome
520			_aA huge number of therapeutic studies has been published in rheumatology and clinical immunology. This number grows substantially by the year. As such, it becomes increasingly difficult to keep track of this multitude of studies and the ensuing therapeutic trends. Further to this, a particular study can be referred to in a variety of ways, either as a shortened version of the title or an acronym, adding to the confusion. The book Clinical Trials in Rheumatology provides a summary of the important studies in the field for easy reference. Every study is shown with name, acronym (if in existence), authors, complete citation, study design, results, and summary. An acronym finder is supplied at the beginning of the book. This book is a valuable reference tool for rheumatologists and other clinical specialties, as well as for research scientists interested in immunomodulatory and selected other drug therapies in rheumatologic diseases. _bCommon terms and phrases: 12 months abatacept ACR 20 ACR Adalimumab anakinra Arthritis Rheum Authors Publication Follow bosentan Change ciclosporin clinical combination comorbidity Concomitant medication continued corticosteroids cyclophosphamide discontinued disease activity DMARDs dose double-blind duration early effective efficacy Etanercept Follow up Note function global assessment gold Headache Hypertension iloprost improvement increased infection Infliximab joint count lupus mean methotrexate methylprednisolone mg ambrisentan mg ETN mg/day mg/dL mg/kg mg/kg/day mg/L mg/week mm/h months Morning stiffness Nausea Note Adverse events oral pain Patients Authors Publication patients with active placebo prednisolone prednisone Previous medication pulses RA patients randomized reduced relapse remission response Result Patients Authors rheumatoid arthritis score severe skin steroids Substance Result Patients Sulfasalazine swollen joints symptoms syndrome systemic tacrolimus Tapered tender joints therapy tocilizumab treated treatment Trial Substance Result weeks
600			_x Medical / Rheumatology _926925
600			_x Medical / Pharmacology _927230
600			_xMedical / Neurology _926948
600			_xMedical / Internal Medicine _926949
600			_x Medical / Dermatology _926960
600			_x Medical / Clinical Medicine _926816
600			_x Medical / Cardiology _926817
600			_xMedical › Internal Medicine _927196
700			_aJohannes von Kempis _938671
942			_2ddc _cEB
999			_c7037 _d7037